Plasmids are essential for the development of viral vectors used to manufacture novel gene therapies and viral vaccines. Aldevron is supporting the innovation of drug developers in this space by providing standardized royalty-free, bulk AAV helper and lentiviral packaging plasmids for research and GMP production.
Aldevron is exhibiting at the CAR-TCR Summit in London February 25 – 27, 2019, and was excited to share the news of our partnership with Oxford Genetics to produce lentivirus. Click here to read the interview with James Brown, Aldevron’s Vice President of Corporate Development about the collaboration.
Earlier this month Aldevron hosted its first scientific conference, the Breakthrough Symposium. We felt the time was right, given 2018 is Aldevron’s 20th anniversary, to invite those in the gene and cell therapy fields to Fargo, North Dakota, for collaboration, networking and fellowship. We were overwhelmed and gratified by the response!